Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Daisy Pireh"'
Autor:
Daisy Pireh, Stevan W. Djuric, Richard J. Sciotti, David Madar, Paul E. Wiedeman, Marina A. Pliushchev, Jonathan Pease, Hana Kopecka
Publikováno v:
Tetrahedron Letters. 42:3681-3684
A method for the intermolecular coupling of aryl bromides and oxazolidinones is described. Application to intermediates useful for the preparation of a known class of antibacterial agent and the synthesis of the known antibacterial oxazolidinone Dup-
Autor:
Pauline M. Johnson, Angela M. Nilius, Daniel T. W. Chu, Daisy Pireh, Yat Sun Or, Robert K. Flamm, Richard L. Elliott, Jacob J. Plattner
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 7:641-646
A series of novel 3-deoxy-3-des-cladinosyl-6- O -methyl erythromycin A analogues has been synthesized and evaluated in vitro for antibacterial activity. These analogues were readily synthesized by tributyltin hydride-mediated radical reduction of a 3
Autor:
Terrance J. Magoc, Richard G. Conway, Douglas H. Steinman, Daisy Pireh, Michael L. Curtin, James H. Holms, James B. Summers, H. Robin Heyman, Steven K. Davidsen, Paul Tapang, Daniel H. Albert, George M. Carrera, George S. Sheppard, Rhein Da
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 5:2913-2918
3-(3-Pyridinyl)-7-(indol-3-ylcarbonyl)-1H-3H-pyrrolo[1,2-c]thiazoles represent a class of potent, orally active PAF antagonists; however, the lead compounds in this series suffered from a lack of aqueous solubility. To overcome this limitation, a num
Autor:
Terrance J. Magoc, Daisy Pireh, George S. Sheppard, H. Robin Heyman, Richard G. Conway, Douglas H. Steinman, James H. Holms, Steven K. Davidsen, Rhein Da, Gongjin Luo, George M. Carrera, Nichael L. Curtin, James B. Summers, Paul Tapang, Daniel H. Albert
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 5:2903-2908
3-(3-Pyridinyl)-7-(indol-3-ylcarbonyl)-1 H -3 H -pyrrolo[1,2-c]thiazoles represent a new class of platelet activating factor antagonists. This series was discovered by combining the indole portion of a previous thiazolidine series with the known 3-py
Autor:
James G. Phillips, Mark G. Bures, Daisy Pireh, William C. Calhoun, Denise E. Guinn, Richard D. Conway, Steven K. Davidsen, T. J. Magoc, George M. Carrera, James B. Summers, Paul D. May, H. Robin Heyman, Rhein Da, Daniel H. Albert, George S. Sheppard, Douglas H. Steinman, George W. Carter
Publikováno v:
Journal of Medicinal Chemistry. 37:2011-2032
(2RS,4R)-3-(2-(3-Pyridinyl)thiazolidin-4-oyl)indoles represent a new class of potent, orally active antagonists of platelet activating factor (PAF). The compounds were prepared by acylation of the magnesium or zinc salts of substituted indoles with (
Autor:
G. M. Jun. Carrera, T. J. Magoc, William C. Calhoun, Daisy Pireh, H. R. Heyman, Rhein Da, S. K. Davidsen, Paul D. May, Richard G. Conway, James B. Summers, Denise E. Guinn, James G. Phillips, George W. Carter, G. S. Sheppard, Daniel H. Albert, D. H. Steinman, M. G. Bures
Publikováno v:
ChemInform. 25
Autor:
Daisy Pireh, James H. Holms, Daniel H. Albert, T. J. Magoc, G. M. Jun. Carrera, G. S. Sheppard, D. H. Steinman, Rhein Da, H. R. Heyman, Paul Tapang, S. K. Davidsen, Richard G. Conway, James B. Summers, Michael L. Curtin
Publikováno v:
ChemInform. 27
Autor:
Richard J. Sciotti, Marina A. Pliushchev, Paul E. Wiedeman, David Madar, Stevan W. Djuric, Jonathan Pease, Hana Kopecka, Daisy Pireh
Publikováno v:
ChemInform. 32
A method for the intermolecular coupling of aryl bromides and oxazolidinones is described. Application to intermediates useful for the preparation of a known class of antibacterial agent and the synthesis of the known antibacterial oxazolidinone Dup-
Autor:
Daisy Pireh, Michael Clare, Robert Bruce Garland, Lydia Swenton, Patricia M. Finnegan, Masateru Miyano
Publikováno v:
The Journal of Organic Chemistry. 55:5854-5861
An improved synthesis of EP 092 was developed. Resolution of an early intermediate was achieved by using butane-2(R), 3(R)-diol ketals. Both enantiomers of EP 092 were found to possess platelet aggregation inhibition activity, but the l enantiomer wa
Autor:
Xiaofeng Li, Thomas W. von Geldern, Kenton L. Longenecker, James M. Trevillyan, Chunqiu Lai, Kent D. Stewart, Bradley J. Backes, Thomas H. Lubben, Daisy Pireh, Anita J Kempf-Grote, Hing L. Sham, Zhonghua Pei, David W A Beno, Stephen J. Ballaron
Publikováno v:
Journal of medicinal chemistry. 50(8)
Dipeptidyl peptidase IV (DPP4) inhibitors are emerging as a new class of therapeutic agents for the treatment of type 2 diabetes. They exert their beneficial effects by increasing the levels of active glucagon-like peptide-1 and glucose-dependent ins